These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 7179292)
1. Binding to mouse brain synaptosomes of Clostridium botulinum type E derivative toxin before and after tryptic activation. Kozaki S; Sakaguchi G Toxicon; 1982; 20(5):841-6. PubMed ID: 7179292 [TBL] [Abstract][Full Text] [Related]
2. Interaction of botulinum type A, B and E derivative toxins with synaptosomes of rat brain. Kozaki S Naunyn Schmiedebergs Arch Pharmacol; 1979 Jul; 308(1):67-70. PubMed ID: 492355 [TBL] [Abstract][Full Text] [Related]
3. Inactivation of Clostridium botulinum type A neurotoxin by trypsin and purification of two tryptic fragments. Proteolytic action near the COOH-terminus of the heavy subunit destroys toxin-binding activity. Shone CC; Hambleton P; Melling J Eur J Biochem; 1985 Aug; 151(1):75-82. PubMed ID: 3896784 [TBL] [Abstract][Full Text] [Related]
4. Affinity chromatography of tetanus toxin, tetanus toxoid, and botulinum A toxin on synaptosomes, and differentiation of their acceptors. Habermann WE Naunyn Schmiedebergs Arch Pharmacol; 1976; 293(1):1-9. PubMed ID: 948349 [TBL] [Abstract][Full Text] [Related]
5. Binding ability of Clostridium botulinum neurotoxin to the synaptosome upon treatment of various kinds of the enzymes. Kitamura M; Sone S Biochem Biophys Res Commun; 1987 Mar; 143(3):928-33. PubMed ID: 3566763 [TBL] [Abstract][Full Text] [Related]
6. Localization of sites for 125I-labelled botulinum neurotoxin at murine neuromuscular junction and its binding to rat brain synaptosomes. Dolly JO; Williams RS; Black JD; Tse CK; Hambleton P; Melling J Toxicon; 1982; 20(1):141-8. PubMed ID: 7043781 [TBL] [Abstract][Full Text] [Related]
7. Binding of Clostridium botulinum type C neurotoxin to rat brain synaptosomes. Agui T; Syuto B; Oguma K; Iida H; Kubo S J Biochem; 1983 Aug; 94(2):521-7. PubMed ID: 6630172 [TBL] [Abstract][Full Text] [Related]
8. Properties of a protease-sensitive acceptor component in mouse brain synaptosomes for Clostridium botulinum type B neurotoxin. Ogasawara J; Kamata Y; Sakaguchi G; Kozaki S FEMS Microbiol Lett; 1991 Apr; 63(2-3):351-5. PubMed ID: 2060767 [TBL] [Abstract][Full Text] [Related]
9. Binding of botulinum neurotoxin to the synaptosome fraction of rat brain. Kitamura M Naunyn Schmiedebergs Arch Pharmacol; 1976 Nov; 295(2):171-5. PubMed ID: 186722 [TBL] [Abstract][Full Text] [Related]
10. Comparison of Clostridium botulinum toxins type D and C1 in molecular property, antigenicity and binding ability to rat-brain synaptosomes. Murayama S; Syuto B; Oguma K; Iida H; Kubo S Eur J Biochem; 1984 Aug; 142(3):487-92. PubMed ID: 6468375 [TBL] [Abstract][Full Text] [Related]
11. Action of botulinum neurotoxin on acetylcholine release from rat brain synaptosomes: putative internalization of the toxin into synaptosomes. Murayama S; Umezawa J; Terajima J; Syuto B; Kubo S J Biochem; 1987 Dec; 102(6):1355-64. PubMed ID: 3129413 [TBL] [Abstract][Full Text] [Related]
12. Botulinum neurotoxin type B. Its purification, radioiodination and interaction with rat-brain synaptosomal membranes. Evans DM; Williams RS; Shone CC; Hambleton P; Melling J; Dolly JO Eur J Biochem; 1986 Jan; 154(2):409-16. PubMed ID: 3753681 [TBL] [Abstract][Full Text] [Related]
13. Binding of botulinum neurotoxin to pure cholinergic nerve terminals isolated from the electric organ of Torpedo. Blasi J; Egea G; Castiella MJ; Arribas M; Solsona C; Richardson PJ; Marsal J J Neural Transm Gen Sect; 1992; 90(2):87-102. PubMed ID: 1334417 [TBL] [Abstract][Full Text] [Related]
14. The use of monoclonal antibodies to analyze the structure of Clostridium botulinum type E derivative toxin. Kozaki S; Kamata Y; Nagai T; Ogasawara J; Sakaguchi G Infect Immun; 1986 Jun; 52(3):786-91. PubMed ID: 2423459 [TBL] [Abstract][Full Text] [Related]
15. Immunological characterization of papain-induced fragments of Clostridium botulinum type A neurotoxin and interaction of the fragments with brain synaptosomes. Kozaki S; Miki A; Kamata Y; Ogasawara J; Sakaguchi G Infect Immun; 1989 Sep; 57(9):2634-9. PubMed ID: 2668181 [TBL] [Abstract][Full Text] [Related]
16. Binding of botulinum type Cl, D and E neurotoxins to neuronal cell lines and synaptosomes. Yokosawa N; Tsuzuki K; Syuto B; Fujii N; Kimura K; Oguma K Toxicon; 1991; 29(2):261-4. PubMed ID: 2048142 [TBL] [Abstract][Full Text] [Related]
17. Structure of Clostridium botulinum type B derivative toxin: inhibition with a fragment of toxin from binding to synaptosomal fraction [proceedings]. Kozaki S; Miyazaki S; Sakaguchi G Jpn J Med Sci Biol; 1978 Apr; 31(2):163-6. PubMed ID: 79664 [No Abstract] [Full Text] [Related]
18. Botulinum type F neurotoxin. Large-scale purification and characterization of its binding to rat cerebrocortical synaptosomes. Wadsworth JD; Desai M; Tranter HS; King HJ; Hambleton P; Melling J; Dolly JO; Shone CC Biochem J; 1990 May; 268(1):123-8. PubMed ID: 2188647 [TBL] [Abstract][Full Text] [Related]
19. Activation of botulinum toxins in the absence of nicking. Ohishi I; Sakaguchi G Infect Immun; 1977 Aug; 17(2):402-7. PubMed ID: 19360 [TBL] [Abstract][Full Text] [Related]
20. ADP-ribosylation of cerebrocortical synaptosomal proteins by cholera, pertussis and botulinum toxins. Ashton AC; Edwards K; Dolly JO Toxicon; 1990; 28(8):963-73. PubMed ID: 1981953 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]